EIQ.XA is trading 26.5% up today at A$1.56 after announcing senior U.S.-focused leadership appointments aimed at accelerating its American expansion and commercial rollout.

  • The company named a new CFO and senior clinical leader to strengthen its ability to scale in the U.S. market.
  • Investors are viewing the strategic executive additions as a meaningful catalyst for the company's growth and commercialization strategy in the United States.